• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

webinar_medical-device-market-authorisation
Monday, 11 September 2023 / Published in Medical Device, News, NMPA Registration in China, Webinars

Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

Cisema is delighted to hold a Masterclass with the FORUM Institut on December 5-6, 2023. The total 6 hours of live webcast will provide detailed updates about recent regulatory changes in China – including the new medical device law which came into force in 2021 and continues to generate substantial new subsidiary regulation. Our local experts will also take you through the steps on how to perfect your pre-market registration (PMR) and post-market surveillance (PMS) in China.

Topics

  • Update your regulatory knowledge
  • Pre-Market Registration: Minimalise your efforts and costs
  • Acceptance of European registration tests
  • Clinical pathways: From feasibility study report to a clinical trial
  • Perfect your cooperation with your NMPA legal agent
  • Chinese IFU and label

Target audiences

The webcasts are aimed at specialists and managers in the medical device and IVD industry who are managing medical device marketing authorisation in China. Good knowledge of the Chinese medical device market and its legal framework is an important prerequisite. This online course is of particular interest for the following departments:

  • Regulatory, clinical and quality affairs
  • Strategy & corporate development
  • Product management
  • Distribution and sales

Basic knowledge on medical device marketing authorisation in China is a prerequiste for the training.

Key takeaways

  • Up-to-date knowledge of the registration authorities in China.
  • Optimisation of pre-market registration (PMR) with minimal effort and cost.
  • Understanding the acceptance of European regulatory testing in China.
  • Insights into clinical pathways from feasibility study report to clinical trial.
  • Improved cooperation with the NMPA legal representative.
  • Information on the Chinese Instructions for Use (IFU) and label requirements.

Details

Date: December 5-6, 2023 (Tuesday & Wednesday)

Time: 9-12 AM CET

Language: English

Agenda

Day 1: Pre-Market Registration (PMR)

  • Products Technical Requirement (PTR): How to write the PTR to minimalize the efforts and costs of change management
  • Registration tests: What must be done in China and what can be done in your own country
  • Clinical pathways
    • From feasibility study report (FSR) to a clinical evaluation report (CER) to a clinical trial: How to find the best pathway and strategy for your individual product?
  • In-depth analysis: How to accelerate the complete process of registration.

Day 2: Post-Market Surveillance (PMS)

  • Legal agent: What must they do for you in China and how can you cooperate
  • Chinese instruction for use (IFU) and label: Who is responsible and how to manage
  • Change management: Systematic analyzation of different change types and examples
  • Random sampling test in China: Facts and trends
  • Adverse Event (AE): How can you establish a system to manage AE

Questions and discussions are explicitly welcome. Take advantage of the interactive opportunity to talk directly to local experts during the Q&A sessions.

At the end of the webcasts, we have prepared an online test for you to test your knowledge. Once you have taken this test, you will have online access to your certificate.

Register

Speakers

Stefan Fischer
Cisema (Hong Kong) Limited
Founder & Managing Director

Hamish King
Cisema (Hong Kong) Limited
CEO

Guo Ning
Cisema Beijing
General Manager, Beijing

Further information

Discover our services for medical device registration, renewals and NMPA Legal Agent or learn more about our upcoming events.​​​​​

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

Cisema Participates in Canada’s Regulatory Medtech Conference 2021
WEBINAR: GO EAST: MARKET POTENTIAL AND PRODUCT REGISTRATION FOR EUROPEAN MEDICAL DEVICES IN CHINA
Quality Control on Coronary Stents Increased Following China’s Recent Centralized Procurement Program

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...
  • China medical device classification catalogue

    China medical device classification catalogue: Navigating latest regulatory adjustments

    China medical device classification catalogue u...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP